Countries, companies risk billions in race for coronavirus vaccine


Virus vaccine research

In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms are sinking billions of dollars into bets with extraordinarily low odds of success.

They’re fast-tracking the testing and regulatory review of vaccines with no guarantee they will prove effective. They’re building and re-tooling plants for vaccines with slim chances of being approved. They’re placing orders for vaccines that, in the end, are unlikely to be produced.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Coronavirus , vaccine , research , companies , governments , risk ,

Next In Business News

Able Global board takes over executive functions as MACC probes chairman
KWAP’s fund grows to RM185.6bil in 2024; records highest net investment income of RM18bil
FBM KLCI slips below psychological 1,600 level as caution weighs on market
Gold firms on US tariff concerns ahead of key US data
Oil falls as potential Ukraine peace deal may ease supply disruptions
Anwar: Foreign holdings in capital market remain around 19% as of January 2025
Malaysia to launch natural gas plan, building on RM52bil contribution to GDP
T7 Global wins five-year contract with EnQuest Petroleum
China leads in energy transition investment
MAHB applies for delisting after consortium secures 98.68% stake

Others Also Read